SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge💹Economics📊Experiments🤖Agents🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
therapeutic 2,050 words KG: ent-dise-bfd8f32d 2026-03-25
section:therapeuticskind:therapeutictopic:cbstopic:psptopic:optogeneticstopic:chemogeneticstopic:dreaddstopic:circuit-manipulationtopic:neuromodulationtopic:deep-brain-stimulationtopic:gene-therapytopic:neural-circuits
Contents

Section 253: Advanced Optogenetics and Chemogenetics for Circuit Manipulation in CBS/PSP

💊 Therapeutic Info
NameSection 253: Advanced Optogenetics and Chemogenetics for Circuit Manipulation in CBS/PSP
SummaryAdvanced optogenetics and chemogenetics (DREADDs) technologies for precise neural circuit manipulation, motor and cognitive symptom relief, and circuit-level understanding in corticobasal syndrome and progressive supranuclear palsy

Knowledge Graph

Related Hypotheses (12)

Purinergic Signaling Polarization Control
Score: 0.71Mechanosensitive Ion Channel Reprogramming
Score: 0.70Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67Oligodendrocyte White Matter Vulnerability
Score: 0.65Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.61

Related Analyses (8)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completedAstrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archivedMicroglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archivedDigital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived

Related Experiments (13)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40

See Also (15)

OSK Reprogramming and Yamanaka Factors in Neurodegenera
mechanism · Pages share 4 hypothesesA 6-month & 18-month Prospective, Randomized, Placebo-c
clinical · Pages share 4 hypothesesA Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 4 hypothesesSynaptic Therapy Alzheimer's Research Trial (START): A
clinical · Pages share 4 hypothesesA Phase 2b, Multicenter, Randomized, Double-Blind, Plac
clinical · Pages share 4 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

SciDEX — scidex.ai — Dashboard | Atlas

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)